C-625
Third Session, Fortieth Parliament,
59-60 Elizabeth II, 2010-2011
HOUSE OF COMMONS OF CANADA
BILL C-625
An Act to amend the Controlled Drugs and Substances Act (amphetamines)
first reading, February 11, 2011
Ms. Davies (Vancouver East)
402250
SUMMARY
This enactment amends the Controlled Drugs and Substances Act to transfer amphetamines from Schedule III to Schedule I, so that the punishment is more severe for offences involving amphetamines.
Also available on the Parliament of Canada Web Site at the following address:http://www.parl.gc.ca
3rd Session, 40th Parliament,
59-60 Elizabeth II, 2010-2011
house of commons of canada
BILL C-625
An Act to amend the Controlled Drugs and Substances Act (amphetamines)
1996, c. 19
Her Majesty, by and with the advice and consent of the Senate and House of Commons of Canada, enacts as follows:
1. Schedule I to the Controlled Drugs and Substances Act is amended by adding the following after item 18:
19.       Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
(1)       amphetamine (α-methylbenzene-ethanamine)
(2)       N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
(3)       4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
(4)       3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
(5)       2,5-dimethoxyamphetamine (2,5-di-methoxy-α-methylbenzene-ethanamine)
(6)       4-methoxyamphetamine (4-methoxy-α-methylbenzene­ethanamine)
(7)       2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzene­ethanamine)
(8)       N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
(9)       4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
(10)       5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzo­dioxole-5-ethanamine)
(11)       N,N-dimethyl-3,4-methylenedioxy- amphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
(12)       N-ethyl-3,4-methylenedioxy- amphetamine (N-ethyl-α-methyl-1,3-benzo­dioxole-5-ethanamine)
(13)       4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
(14)       4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
(15)       4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
(16)       4-ethoxyamphetamine (4-ethoxy-α-methylbenzene­ethanamine)
(17)       Benzphetamine (N-benzyl-N,α-dimethylbenzene­ethanamine)
(18)       N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzo­dioxole-5-ethanamine)
(19)       N-(2-Hydroxyethyl)-α-meth-ylbenzene­ethanamine
(20)       N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
(21)       3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzene­ethanamine)
20.       Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives
21.       4-hydroxybutanoic acid (GHB) and any of its salts
2. Item 1 of Schedule III to the Act is repealed.
3. Items 25 and 26 of Schedule III to the Act are repealed.
Published under authority of the Speaker of the House of CommonsAvailable from:Publishing and Depository ServicesPublic Works and Government Services Canada